PSS12 Nepafenac for the Reduction in Risk of Post-Operative Macular Oedema Associated With Cataract Surgery in Diabetic Patients- A Cost-Effectiveness Estimation for Scotland
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2059
https://www.valueinhealthjournal.com/article/S1098-3015(12)03772-2/fulltext
Title :
PSS12 Nepafenac for the Reduction in Risk of Post-Operative Macular Oedema Associated With Cataract Surgery in Diabetic Patients- A Cost-Effectiveness Estimation for Scotland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03772-2&doi=10.1016/j.jval.2012.08.2059
First page :
A570
Section Title :
Sensory Systems Disorders
Open access? :
No
Section Order :
1544